Company news
Edesa Biotech, Inc. news in 2021
Edesa Biotech, Inc.'s news releases, calls and decks from 2021, newest first.
Edesa Biotech Reports Fiscal Year 2021 Results
December 27, 2021
Edesa Biotech Marks Enrollment Milestone in Dermatitis Study
November 30, 2021
Edesa Biotech Extends COVID-19 Clinical Study to Poland
November 3, 2021
Edesa Biotech Reports Favorable Mortality Reductions in COVID-19 Study
October 18, 2021
Edesa Biotech Announces Positive Phase 2 Data of Its Monoclonal Antibody in Hospitalized COVID-19 Patients
September 19, 2021
Edesa Biotech to Present at the H.C. Wainwright Global Investment Conference
September 8, 2021
Edesa Biotech Enrolls More Than 525 COVID-19 Patients Ahead of Schedule
August 25, 2021
Edesa Biotech Reports Fiscal 3rd Quarter 2021 Financial Results
August 12, 2021
Edesa Biotech Extends Dermatitis Study to Canada
July 12, 2021
Edesa Biotech Team Expands Leadership Team with Key Manufacturing Appointment
June 22, 2021
Edesa Biotech Reports Favorable Review of COVID-19 Study
June 17, 2021
Edesa Biotech to Attend BIO Digital 2021
June 7, 2021
Edesa Biotech Reports Positive Interim Results in Dermatitis Trial
June 2, 2021
Edesa Biotech to Join Panel Discussion at Industry Event
May 27, 2021
Edesa Biotech Reports Fiscal 2nd Quarter 2021 Results
May 13, 2021
Edesa Biotech to Host Key Opinion Leader Webinar on EB05 for the Treatment of Acute Respiratory Distress Syndrome
April 21, 2021
Edesa Biotech Expands Rights to Anti-Inflammatory Technology
March 21, 2021
Edesa Biotech Reaches Enrollment Milestone in COVID Study
March 14, 2021
Edesa Biotech Completes Enrollment for Interim Clinical Study Milestone
March 8, 2021
Edesa Biotech Announces Closing of $10 Million Bought Deal Offering of Common Shares
March 1, 2021
Edesa Biotech Increases Previously Announced Bought Deal Offering of Common Shares to $10.0 Million
February 24, 2021
Edesa Biotech Announces $3.5 Million Bought Deal Offering of Common Shares
February 24, 2021
Edesa Biotech Reports Fiscal First Quarter 2021 Results
February 15, 2021
Edesa Biotech Receives C$14 million for COVID-19 Study
February 1, 2021
Edesa Biotech to Study Its Investigational Drug as Potential Rescue Therapy
January 25, 2021
Edesa Biotech to Join Panel Discussion at Government COVID-19 Event
January 19, 2021
Edesa Biotech Expands COVID-19 Clinical Study to Colombia
January 10, 2021